Cargando…

Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents

Several MRI contrast agent clinical formulations are now known to leave deposits of the heavy metal gadolinium in the brain, bones, and other organs of patients. This persistent biological accumulation of gadolinium has been recently recognized as a deleterious outcome in patients administered Gd-ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rees, Julian A., Deblonde, Gauthier J.-P., An, Dahlia D., Ansoborlo, Camille, Gauny, Stacey S., Abergel, Rebecca J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849765/ https://www.ncbi.nlm.nih.gov/pubmed/29535330 http://dx.doi.org/10.1038/s41598-018-22511-6

Ejemplares similares

Efficient discrimination of transplutonium actinides by in vivo models
por: Pallares, Roger M., et al.
Publicado: (2021)

Combinatorial design of multimeric chelating peptoids for selective metal coordination
por: Ricano, Abel, et al.
Publicado: (2019)

In situ beam reduction of Pu(IV) and Bk(IV) as a route to trivalent transuranic coordination complexes with hydroxypyridinone chelators
por: Carter, Korey P., et al.
Publicado: (2022)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Gadolinium contrast agents: dermal deposits and potential effects on epidermal small nerve fibers
por: Krämer, Heidrun H., et al.
Publicado: (2023)

Ultra-selective ligand-driven separation of strategic actinides
por: Deblonde, Gauthier J.-P., et al.
Publicado: (2019)

Hydroxypyridinone Derivatives: A Low-pH Alternative to Polyaminocarboxylates for TALSPEAK-like Separation of Trivalent Actinides from Lanthanides
por: Wang, Yufei, et al.
Publicado: (2020)

Safety of gadolinium based contrast agents in magnetic resonance imaging-guided radiotherapy – An investigation of chelate stability using relaxometry
por: Mahmood, Faisal, et al.
Publicado: (2022)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Revisiting the risks of MRI with Gadolinium based contrast agents—review of literature and guidelines
por: Khawaja, Aurang Z., et al.
Publicado: (2015)

Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma
por: Patil, Rameshwar, et al.
Publicado: (2020)

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
por: Gallo, Enrico, et al.
Publicado: (2020)

Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
por: Le Duc, Géraldine, et al.
Publicado: (2014)

Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent
por: Franckenberg, Sabine, et al.
Publicado: (2017)

Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
por: Jeong, Yohan, et al.
Publicado: (2018)

Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents
por: Hojreh, Azadeh, et al.
Publicado: (2020)

Gadolinium-doped fluorescent carbon quantum dots as MRI contrast agents and fluorescent probes
por: Molaei, Mohammad Jafar
Publicado: (2022)

Gadolinium-Based Contrast Agents in Pregnant Women: A Literature Review of MRI Safety
por: Alghamdi, Sami A
Publicado: (2023)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Dextran-based Nanomicelle System with Directly Ester-bound Gadolinium Chelates as a Magnetic Resonance Imaging Contrast Agent for Tumor Detection
por: Ma, Lirong, et al.
Publicado: (2020)

Gadolinium-based Contrast Media, Cerebrospinal Fluid and the Glymphatic System: Possible Mechanisms for the Deposition of Gadolinium in the Brain
por: Taoka, Toshiaki, et al.
Publicado: (2018)

The Effect of Magnetic Field Gradient and Gadolinium-Based MRI Contrast Agent Dotarem on Mouse Macrophages
por: Chanana, Priyanka, et al.
Publicado: (2022)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals
por: Carter, Korey P., et al.
Publicado: (2020)

Comparing the signal enhancement of a gadolinium based and an iron-oxide based contrast agent in low-field MRI
por: van Zandwijk, Jordy K., et al.
Publicado: (2021)

Is the Transport of a Gadolinium-Based Contrast Agent Decreased in a Degenerated or Aged Disc? A Post Contrast MRI Study
por: Tibiletti, Marta, et al.
Publicado: (2013)

Fibromyalgia associated with repeated gadolinium contrast-enhanced MRI examinations
por: Lattanzio, Silvia Maria, et al.
Publicado: (2020)

MRI spot sign: Gadolinium contrast extravasation in an expanding intracerebral hematoma on MRI
por: Allam, Talha, et al.
Publicado: (2019)

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T(1) contrast
por: Ananta, Jeyarama S., et al.
Publicado: (2010)

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
por: Nucera, Eleonora, et al.
Publicado: (2021)

Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)
por: Năstase, Florentina, et al.
Publicado: (2021)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Fatima, Atiya, et al.
Publicado: (2021)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

Cerebral blood perfusion deficits using dynamic susceptibility contrast MRI with gadolinium chelates in rats with post-ischemic reperfusion without significant dynamic contrast-enhanced MRI-derived vessel permeabilities: A cautionary note
por: Jin, Seokha, et al.
Publicado: (2018)

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents
por: Silva, Simone Rodrigues, et al.
Publicado: (2015)

The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytes
por: Friebe, Björn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e7g0gl7bkplrcuispma42spmq6